PR Newswire (US)·AR·
Zemcelpro® distribution agreement announced for Argentina, Hong Kong and Singapore
Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, is conditionally authorized by the European Commission for the treatment of certain hematological malignancies FarmaMondo has been granted distribution rights for Zemcelpro® in Argentina, Hong Kong and Singapore MONTREAL, July...
Read releases like this the second they cross the wire.
1,200+ feeds from 80+ newswires in one live cockpit — saved searches, instant alerts, AI summaries. 7-day free trial, no card required.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live on PPN World.
PPN Source →Shared via PPN World — real-time press release intelligence.